Synapse - Works

Results (5608)

NeuACT, a Phase 2 randomised, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence: Updated analysis of product parameters and safety

Meeting Abstract

Bajorin, D.; Sharma, R.; O'Donnell, P. H.; Sims, R.; DeVries, T.; Sheikh, N.; Gomella, L. G.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels

Journal Article

Pu, Y.; Xue, J.; Wang, W.; Xu, B.; Gu, Y.; Tang, R.; Ackerstaff, E.; Koutcher, J. A.; Achilefu, S.; Alfano, R. R.
Journal of Biomedical Optics (2013)

Fulltext@MSK | Save

Perturbation Biology: Inferring Signaling Networks in Cellular Systems

Journal Article

Molinelli, E. J.; Korkut, A.; Wang, W.; Miller, M. L.; Gauthier, N. P.; Jing, X.; Kaushik, P.; He, Q.; Mills, G.; Solit, D. B.; more...
PLoS Computational Biology (2013)

Fulltext@MSK | Save

Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure

Journal Article

Autio, K. A.; Bennett, A. V.; Jia, X.; Fruscione, M.; Beer, T. M.; George, D. J.; Carducci, M. A.; Logothetis, C. J.; Kane, R. C.; Sit, L.; more...
Journal of Oncology Practice (2013)

Fulltext@MSK | Save

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer

Journal Article

Rathkopf, D. E.; Morris, M. J.; Fox, J. J.; Danila, D. C.; Slovin, S. F.; Hager, J. H.; Rix, P. J.; Chow-Maneval, E.; Chen, I.; Gonen, M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial

Journal Article

Motzer, R. J.; Nosov, D.; Eisen, T.; Bondarenko, I.; Lesovoy, V.; Lipatov, O.; Tomczak, P.; Lyulko, O.; Alyasova, A.; Harza, M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma

Journal Article

Hakimi, A. A.; Furberg, H.; Zabor, E. C.; Jacobsen, A.; Schultz, N.; Ciriello, G.; Mikkilineni, N.; Fiegoli, B.; Kim, P. H.; Voss, M. H.; more...
JNCI: Journal of the National Cancer Institute (2013)

Fulltext@MSK | Save

Validation of the aDNA test prostate assay sensitivity in detecting prostate-associated transcripts compared to the veridex cellsearch enumeration assay in patients with prostate sancer

Meeting Abstract

Samoila, A.; Bastos, D. A.; Anand, A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N.; Fleisher, M.; Scher, H. I.; Danila, D. C.
Journal of Molecular Diagnostics (2013)

Fulltext@MSK | Save

A phase 3 comparative study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus everolimus in patients with advanced or metastatic renal cell carcinoma (mRCC) previously treated with anti-angiogenic therapy

Meeting Abstract

Motzer, R. J.; Bono, P.; Tomita, Y.; Ravaud, A.; Waxman, I.; Gore, M. E.
BJU International (2013)

Fulltext@MSK | Save

A phase 3 randomized study of cabozantinib (XL184) vs everolimus in subjects with clear cell renal cell carcinoma (METEOR)

Meeting Abstract

Choueiri, T. K.; Escudier, B.; Powles, T.; Cella, D.; Lee, Y.; Laird, D. A.; Scheffold, C.; Motzer, R. J.
BJU International (2013)

Fulltext@MSK | Save